From: Associations between circadian misalignment and telomere length in BD: an actigraphy study
Variables | N | % | Median | IQR |
---|---|---|---|---|
Sex (females) | 62 | 61.4% | Â | Â |
Age |  |  | 42.6 | 33.8–54.2 |
BD type 1 | 75 | 74.3% | Â | Â |
Age at onset |  |  | 24 | 20–30 |
Duration of BD |  |  | 15 | 10–25 |
Number of episodes |  |  | 6 | 4–9 |
Number of mood stabilizers |  |  | 1 | 1–2 |
Lithium | 66 | 65.3% | Â | Â |
Anticonvulsants | 48 | 47.5% | Â | Â |
Antipsychotics | 32 | 31.7% | Â | Â |
Antidepressants | 29 | 28.7% | Â | Â |
Benzodiazepines | 11 | 10.9% | Â | Â |
Body Mass Index |  |  | 24.5 | 22.5–27.8 |
Sleep apnea risk | 19 | 18.8% | Â | Â |
Tobacco current smoker | 48 | 47.5% | Â | Â |
Past lifetime alcohol misuse | 31 | 30.7% | Â | Â |
MADRS |  |  | 2 | 0–4 |
YMRS |  |  | 0 | 0–1 |
M10 onset (hours) |  |  | 10:00 | 8:00–11:00 |
L5 onset (hours) |  |  | 1:00 | 0:00–2:00 |
CSMa total score |  |  | 36 | 30–42 |
Chronotype categories | ||||
 Morning | 18 | 17.8% |  |  |
 Intermediate | 53 | 52 5% |  |  |
 Evening | 30 | 29.7% |  |  |
Telomere length |  |  | 2.9 | 2.3–3.8 |